Pharma Unlimited

Follow Pharma Unlimited
Share on
Copy link to clipboard

Welcome to Pharma Unlimited, by Wolters Kluwer. Join host Bertrand Bodson as we go under the microscope to examine some of the biggest issues facing the pharma sector. What will the arrival of Big Tech mean for innovation, risk, and regulation? How will t


    • Jan 17, 2022 LATEST EPISODE
    • infrequent NEW EPISODES
    • 28m AVG DURATION
    • 5 EPISODES


    Search for episodes from Pharma Unlimited with a specific topic:

    Latest episodes from Pharma Unlimited

    Can ethics keep pace with pharma innovation?

    Play Episode Listen Later Jan 17, 2022 26:08


    In this episode, Klaus Moosmayer, Chief Ethics, Risk and Compliance Officer at Novartis speaks with Pharma Unlimited podcast host, Bertrand Bodson, about ethics and the ability for them to keep up with innovation in the pharma industry.

    Does pharma need a mission reset?

    Play Episode Listen Later Jan 17, 2022 30:24


    Does the pharma industry need to re-evaluate the role it plays in tacking the big issues of our time? The topic is up for debate in the next episode of the Pharma Unlimited podcast, where Michelle Nunn, President & CEO at CARE joins Pharma Unlimited podcast host Bertrand Bodson.

    Can Big Tech help to de-risk personalized medicine?

    Play Episode Listen Later Dec 1, 2021 27:50


    In the first episode of our Pharma Unlimited podcast, host Bertrand Bodson and Dr. Peter Lee, Corporate Vice President of Research and Incubation at Microsoft Healthcare, discuss the role Big Tech can play in reducing risk in medicine. This episode looks at the different mindsets between the tech and pharma industries coming together, across the value of intellectual property and more.

    Safety and efficacy at speed

    Play Episode Listen Later Dec 1, 2021 28:59


    Sir John Bell, Regius Professor of Medicine at Oxford University, joins Bertrand Bodson on the latest episode of the Pharma Unlimited podcast. Sir John founded the Wellcome Trust Centre for Human Genetics, and most recently led the program for the AstraZeneca-Oxford COVID-19 vaccine. Sir John tells the story of the Oxford vaccine, and takes a closer look at how the pharma industry might handle risk differently in the future.

    Big Tech - Friend or Foe?

    Play Episode Listen Later Dec 1, 2021 29:44


    Karim Lakhani, Professor of Business Administration at the Harvard Business School, joins Pharma Unlimited host Bertrand Bodson to ask what the pharma and tech industries can learn from each other, and where new risk may arise as they begin to collaborate more closely.

    Claim Pharma Unlimited

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel